
    
      1. Subjects who voluntarily signed a consent form and met all inclusion / exclusion
           criteria should enroll in this study.

        2. Subjects enrolled in the study will be randomized and assigned to either Group1 or
           Group2 in a 1: 1 ratio.

        3. Apply EVERA RAPHA for 4 weeks

      3. Measure breast circumference and breast volume at Baseline and 4weeks later 4. Visit after
      4 weeks to evaluate safety and effectiveness
    
  